Work History

Work History

Professional Organizations

American Association for the Advancement of Science, American Diabetes Association, American Heart Association, American Physiological Society, Endocrine Society, Obesity Society, Sigma Xi


AM Nuotio-Antar, AH Hasty, WJ Kovacs. Quantitation and cellular localization of 11beta-HSD1 expression in murine thymus. J Steroid Biochem Mol Biol. 2006 May; 99(2-3):93-9. 

ML Gruen, V Saraswathi, AM Nuotio-Antar, MR Plummer, KR Coenen, AH Hasty. Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice. Atherosclerosis. 2006 May; 186(1):54-64. 

AM Nuotio-Antar, DL Hachey, AH Hasty. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.  Am J Physiol Endocrinol Metab.  2007 Dec; 293(6): E1517-28.

MV Li, W Chen, RN Harmancey, AM Nuotio-Antar, M Imamura, P Saha, H Taegtmeyer, L Chan.  Glucose-6-phosphate mediates activation of the carbohydrate responsive binding protein (ChREBP).  Biochem Biophys Res Commun. 2010 May 7. 395(3):395-400.


The chief goal of Dr. Alli Antar's research is to elucidate the mechanisms whereby certain genes impact cell function in metabolic tissues. In graduate school at Vanderbilt University, with funding from the National Institutes of Health as well as the Lupus Foundation of America, Dr. Antar's project focused on the role of the enzyme 11beta-hydroxysteroid dehydrogenase type 1 in modulating lipid metabolism, as well as on its expression in and potential impact on the development of thymocytes. As a postdoctoral fellow, with the help of awards from the National Institutes of Health as well as a fellowship from the American Heart Association, Dr. Antar's research continued to focus on metabolism and the impact of the immune system on the function of key metabolic tissues. She is currently conducting research at Baylor College of Medicine and is actively involved in scientific societies that are both general in scope and specific to her field. In addition to her research, Alli Antar enjoys supervising and training graduate and undergraduate students in the lab, as well as reviewing manuscripts for several journals in her area of scientific specialization.


adipose tissue, atherosclerosis, autoimmune disease, cancer, dyslipidemia, enzyme kinetics, glucocorticoids, inflammation, insulin resistance, lipids, metabolism, NAFLD, nuclear hormone receptors, obesity, physiology, steroid metabolism, transcription factors, type 2 diabetes